BioNTech SE (ETR:22UA)
Germany · Delayed Price · Currency is EUR 74.55
-2.00 (-2.61%)
At close: Mar 27, 2026
BioNTech SE Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1,136 | -665.3 | 930.3 | 9,434 | 10,293 |
Depreciation & Amortization | 185.3 | 156.6 | 183.4 | 123.3 | 75.2 |
Loss (Gain) From Sale of Assets | -2.5 | -0.3 | 3.8 | 0.6 | 4.6 |
Asset Writedown & Restructuring Costs | 197.5 | 141.4 | - | - | - |
Loss (Gain) From Sale of Investments | -10.4 | 4.6 | 175.5 | -241 | 57.3 |
Stock-Based Compensation | 80.9 | -53.6 | -714.8 | 56.8 | 80.5 |
Other Operating Activities | 603.5 | -596.3 | -781.6 | -315.2 | 1,110 |
Change in Accounts Receivable | 1,084 | 387.7 | 5,374 | 4,370 | -11,808 |
Change in Inventory | 177.9 | 74.5 | 81.9 | 62.9 | -438.4 |
Change in Accounts Payable | -723.8 | 758.4 | 118.9 | 85.7 | 1,516 |
Operating Cash Flow | 456 | 207.7 | 5,371 | 13,577 | 889.7 |
Operating Cash Flow Growth | 119.55% | -96.13% | -60.44% | 1426.07% | - |
Capital Expenditures | -175.1 | -286.5 | -250.1 | -329.2 | -127.5 |
Sale of Property, Plant & Equipment | 4.5 | 1.2 | - | 0.6 | 3.4 |
Cash Acquisitions | 186.3 | - | -336.9 | - | -20.8 |
Sale (Purchase) of Intangibles | -573.9 | -165.8 | -455.4 | -34.1 | -26.5 |
Investment in Securities | -1,910 | -1,630 | -5,912 | 327.4 | -394.7 |
Investing Cash Flow | -2,469 | -2,081 | -6,955 | -35.3 | -566.1 |
Long-Term Debt Issued | 6.7 | - | 0.3 | 0.8 | - |
Long-Term Debt Repaid | -57.6 | -45.9 | -40.4 | -59.9 | -66.7 |
Net Debt Issued (Repaid) | -50.9 | -45.9 | -40.1 | -59.1 | -66.7 |
Issuance of Common Stock | - | - | - | 110.5 | 163.6 |
Repurchase of Common Stock | - | - | -738.5 | -986.4 | - |
Other Financing Activities | -2 | - | - | - | -2.7 |
Financing Cash Flow | -52.9 | -45.9 | -778.6 | -1,419 | 94.2 |
Foreign Exchange Rate Adjustments | -27 | 14.8 | -14.5 | 60.1 | 64.7 |
Miscellaneous Cash Flow Adjustments | 5.9 | 2.8 | 164.8 | -0.5 | - |
Net Cash Flow | -2,087 | -1,902 | -2,211 | 12,182 | 482.5 |
Free Cash Flow | 280.9 | -78.8 | 5,121 | 13,248 | 762.2 |
Free Cash Flow Growth | - | - | -61.34% | 1638.15% | - |
Free Cash Flow Margin | 9.79% | -2.86% | 134.10% | 76.53% | 4.02% |
Free Cash Flow Per Share | 1.16 | -0.33 | 21.10 | 53.03 | 2.94 |
Cash Interest Paid | 11 | 13.5 | 5.4 | 21.5 | 12.2 |
Cash Income Tax Paid | -3.8 | 389.2 | 482.9 | 4,222 | 3,458 |
Levered Free Cash Flow | -1,098 | -548.4 | 4,139 | 12,009 | -646.6 |
Unlevered Free Cash Flow | -1,089 | -537.84 | 4,144 | 12,020 | -629.54 |
Change in Working Capital | 537.8 | 1,221 | 5,575 | 4,519 | -10,730 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.